Coronary Revascularization
Also known as: Repeat coronary revascularization / Coronary revascularisation
Drug | Drug Name | Drug Description |
---|---|---|
DB06441 | Cangrelor | A P2Y12 platelet receptor antagonist used during percutaneous coronary intervention to reduce the risk for periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST). |
DB01394 | Colchicine | An alkaloid used to treat gout and Familial Mediterranean Fever as well as prevent major cardiovascular events. |
DB09303 | Evolocumab | A PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor antibody used as an adjunct to LDL cholesterol reducing therapies, aiding in the prevention of cardiovascular events and cardiovascular revascularization procedures. |
DB00227 | Lovastatin | An HMG-CoA reductase inhibitor used to lower LDL cholesterol and reduce the risk of cardiovascular disease and associated conditions, including myocardial infarction and stroke. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09303 | Evolocumab | 4 | Recruiting | 1 |